All posts in Stem Cell Research
A recent U.S. Court of Appeals decision brought NeoStem, Inc. (AMEX: NBS, StockTwits: $NBS) into the news with the overturning of an earlier district court injunction against federal funding for embryonic stem cell (ESC) research. Justice Department attorneys successfully pressed …
NeoStem, Inc. (AMEX: NBS, StockTwits: $NBS) announced that its majority-owned Suzhou Erye Pharmaceutical Company Ltd. subsidiary recently received two awards at the Chempharm Brand Summit 2011 held in
Bioheart, Inc. (OTCBB: BHRT, Twitter: $BHRT) has released a corporate Power Point presentation to further educate investors about the Bioheart technologies as a new therapy for heart disease.
Bioheart, Inc. (OTCBB:BHRT) is a biotechnology company focused 100 percent on cell therapy products for the heart. Specialized as such and led by a team of industry
Medistem (MEDS.PK) Shares up Big on Stem Cell News Shares of Medistem, Inc. are soaring today after the Company released news of a peer-reviewed publication on its data
It was only eight days ago that Advanced Cell Technology (“ACT”) announced that they have been granted U.S. Food and Drug Administration approval to proceed with human studies
Advanced Cell Technology (ACTC.OB) and Geron (GERN) Offering Hope to Paralysis and Stargardt’s Macular Dystrophy Patients.
Earlier this month, a historic moment happened; human embryonic stem cells were used to treat a patient in Atlanta. Geron Corporation received the first United States Food
With Geron Corp (GERN) now receiving clearance from the U.S. Food and Drug Administration to proceed with human trials of stem cell research on spinal injury patients and
A recent poll conducted by Harris Interactive/Healthday spanning a wide spectrum of demographic groups, including Republicans, Catholics and born-again Christians, showed that an overwhelming amount of Americans support
Advance Cell Technology, Inc. (“ACT”), an industry leader in regenerative medicine arena, recently announced that it has safely and successfully completed Phase I human trials of its myoblast